tiprankstipranks
Trending News
More News >
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market
Advertisement

Halozyme (HALO) Technical Analysis

Compare
1,120 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
6Neutral
10Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Halozyme Therapeutics’s (HALO) Moving Averages Convergence Divergence (MACD) indicator is 0.78, suggesting Halozyme Therapeutics is a Sell.
Halozyme Therapeutics’s (HALO) 20-Day exponential moving average is 70.01, while Halozyme Therapeutics’s (HALO) share price is $68.1, making it a Sell.
Halozyme Therapeutics’s (HALO) 50-Day exponential moving average is 69.16, while Halozyme Therapeutics’s (HALO) share price is $68.1, making it a Sell.

Halozyme (HALO) Pivot Points

Dec 03, 2025, 07:58 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
68.05
69.27
70.33
71.55
72.62
73.84
74.91
Fibonacci
69.27
70.14
70.68
71.55
72.43
72.97
73.84
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (HALO) Moving Averages

Dec 03, 2025, 07:58 AM
Period
Simple
Exponential
MA5
71.80Sell
70.61Sell
MA10
70.92Sell
70.67Sell
MA20
69.92Sell
70.01Sell
MA50
69.16Sell
69.16Sell
MA100
67.98Buy
67.22Buy
MA200
63.00Buy
62.79Buy
Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 70.67, while Halozyme Therapeutics’s (HALO) share price is $68.1, making it a Sell.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 67.22, while Halozyme Therapeutics’s (HALO) share price is $68.1, making it a Buy.
Halozyme Therapeutics’s (HALO) stock price is $68.1 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 69.16, creating a Sell signal.
Halozyme Therapeutics’s (HALO) stock price is $68.1 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 67.98, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $68.1 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 63.00, creating a Buy signal.

Halozyme (HALO) Technical Indicators

Dec 03, 2025, 07:58 AM
Name
Value
Implied Action
RSI (14)
44.46
Neutral
STOCH (9,6)
43.12
Neutral
STOCHRSI (14)
48.50
Neutral
MACD (12,26)
0.78
Sell
ADX (14)
26.03
Neutral
Williams %R
-89.72
Buy
CCI (14)
-29.83
Neutral
ATR (14)
2.39
-
Ultimate Oscillator
45.26
Neutral
ROC
0.13
Buy
Halozyme Therapeutics’s (HALO) Relative Strength Index (RSI) is 44.46, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Trend Strength Indicator (ADX) is 26.03, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Commodity Channel Index (CCI) is -29.83, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Price Rate of Change (ROC) is 0.13, creating a Buy signal.

FAQ

Is HALO a Buy, Hold, or Sell?
Based on HALO’s technical indicators, HALO is a Sell.
    What is HALO’s RSI (14)?
    HALO’s RSI (14) is 44.46, which suggests HALO is a Neutral.
      What is HALO’s MACD?
      HALO’s MACD is 0.78, which suggests HALO is a Sell.
        What is HALO’s 5-day moving average?
        HALO’s 5-day moving average is 71.80, which suggests HALO is a Sell.
          What is HALO’s 20-day moving average?
          HALO 20-day moving average is 69.92, which suggests HALO is a Sell.
            What is HALO’s 50-day moving average?
            HALO’s 50-day moving average is 69.16, which suggests HALO is a Sell.
              What is HALO’s 200-day moving average?
              HALO’s 200-day moving average is 63.00, which suggests HALO is a Buy.
                What is HALO’s Williams % R (14)?
                HALO’s Williams % R (14) is -89.72, which suggests HALO is a Buy.
                  What is HALO’s CCI (14)?
                  HALO’s CCI (14) is -29.83, which suggests HALO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis